It’s more than just numbers on a calendar—it’s a matter of survival. In this race against disease, competitors and time, facility construction speed should never be the heaviest anchor holding you back. We’ve prepared four tough questions for every biotech founder, CEO and investor. When you’re raising capital for your next milestone, these are questions you need to ask yourself.
